– Reuters
Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary
The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA)…
Earlier, NY Fed Said ‘The Global Supply Chains Have Returned To Normal’
– Reuters
Related Posts
AVITA Medical Announces Distribution Partnership With PolyMedics Innovations To Expand to Europe
AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)))) (the "Company"), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin
Northrop Grumman Elects Robert Fleming Corporate Vice President And President, Space Systems
Northrop Grumman Corporation (NYSE:NOC) announces that its board of directors has elected Robert Fleming corporate vice president and president, Space Systems sector, effective October 9, 2023. Fleming will succeed Tom
Activision Boss Bobby Kotick Thinks Video Games Over Elon Musk’s Neuralink Will One Day Become A Reality
Activision Blizzard CEO Bobby Kotick believes we will one day play games using a Neuralink-like neural interface.